• Something wrong with this record ?

GATOR1-related focal cortical dysplasia in epilepsy surgery patients and their families: A possible gradient in severity

B. Benova, MWCB. Sanders, A. Uhrova-Meszarosova, A. Belohlavkova, B. Hermanovska, V. Novak, D. Stanek, M. Vlckova, J. Zamecnik, E. Aronica, KPJ. Braun, BPC. Koeleman, FE. Jansen, P. Krsek

. 2021 ; 30 (-) : 88-96. [pub] 20210106

Language English Country Great Britain

Document type Case Reports, Journal Article

BACKGROUND: Variants of GATOR1-genes represent a recognised cause of focal cortical dysplasia (FCD), the most common structural aetiology in paediatric drug-resistant focal epilepsy. Reports on familial cases of GATOR1-associated FCD are limited, especially with respect to epilepsy surgery outcomes. METHODS: We present phenotypical manifestations of four unrelated patients with drug-resistant focal epilepsy, FCD and a first-degree relative with epilepsy. All patients underwent targeted gene panel sequencing as a part of the presurgical work up. Literature search was performed to compare our findings to previously published cases. RESULTS: The children (probands) had a more severe phenotype than their parents, including drug-resistant epilepsy and developmental delay, and they failed to achieve seizure freedom post-surgically. All patients had histopathologically confirmed FCD (types IIa, IIb, Ia). In Patient 1 and her affected father, we detected a known pathogenic NPRL2 variant. In patients 2 and 3 and their affected parents, we found novel likely pathogenic germline DEPDC5 variants. In family 4, we detected a novel variant in NPRL3. We identified 15 additional cases who underwent epilepsy surgery for GATOR1-associated FCD, with a positive family history of epilepsy in the literature; in 8/13 tested, the variant was inherited from an asymptomatic parent. CONCLUSION: The presented cases displayed a severity gradient in phenotype with children more severely affected than the parents. Although patients with GATOR1-associated FCD are considered good surgical candidates, post-surgical seizure outcome was poor in our familial cases, suggesting that accurate identification of the epileptogenic zone may be more challenging in this subgroup of patients.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21019527
003      
CZ-PrNML
005      
20210830101121.0
007      
ta
008      
210728s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ejpn.2020.12.001 $2 doi
035    __
$a (PubMed)33461085
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Benova, Barbora $u Department of Paediatric Neurology, Motol Epilepsy Center, 2nd Faculty of Medicine, Charles University and Motol University Hospital, V Uvalu 84, 15006, Prague, Czech Republic; Neurogenetics Laboratory of the Department of Paediatric Neurology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, V Uvalu 84, Prague, 15006, Czech Republic. Electronic address: barbora.benova@fnmotol.cz
245    10
$a GATOR1-related focal cortical dysplasia in epilepsy surgery patients and their families: A possible gradient in severity / $c B. Benova, MWCB. Sanders, A. Uhrova-Meszarosova, A. Belohlavkova, B. Hermanovska, V. Novak, D. Stanek, M. Vlckova, J. Zamecnik, E. Aronica, KPJ. Braun, BPC. Koeleman, FE. Jansen, P. Krsek
520    9_
$a BACKGROUND: Variants of GATOR1-genes represent a recognised cause of focal cortical dysplasia (FCD), the most common structural aetiology in paediatric drug-resistant focal epilepsy. Reports on familial cases of GATOR1-associated FCD are limited, especially with respect to epilepsy surgery outcomes. METHODS: We present phenotypical manifestations of four unrelated patients with drug-resistant focal epilepsy, FCD and a first-degree relative with epilepsy. All patients underwent targeted gene panel sequencing as a part of the presurgical work up. Literature search was performed to compare our findings to previously published cases. RESULTS: The children (probands) had a more severe phenotype than their parents, including drug-resistant epilepsy and developmental delay, and they failed to achieve seizure freedom post-surgically. All patients had histopathologically confirmed FCD (types IIa, IIb, Ia). In Patient 1 and her affected father, we detected a known pathogenic NPRL2 variant. In patients 2 and 3 and their affected parents, we found novel likely pathogenic germline DEPDC5 variants. In family 4, we detected a novel variant in NPRL3. We identified 15 additional cases who underwent epilepsy surgery for GATOR1-associated FCD, with a positive family history of epilepsy in the literature; in 8/13 tested, the variant was inherited from an asymptomatic parent. CONCLUSION: The presented cases displayed a severity gradient in phenotype with children more severely affected than the parents. Although patients with GATOR1-associated FCD are considered good surgical candidates, post-surgical seizure outcome was poor in our familial cases, suggesting that accurate identification of the epileptogenic zone may be more challenging in this subgroup of patients.
650    _2
$a mladiství $7 D000293
650    _2
$a dítě $7 D002648
650    _2
$a refrakterní epilepsie $x genetika $7 D000069279
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a proteiny aktivující GTPasu $x genetika $7 D020690
650    _2
$a zárodečné mutace $7 D018095
650    _2
$a lidé $7 D006801
650    _2
$a magnetická rezonanční tomografie $7 D008279
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a malformace mozkové kůry $x genetika $x chirurgie $7 D054220
650    _2
$a fenotyp $7 D010641
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a nádorové supresorové proteiny $x genetika $7 D025521
655    _2
$a kazuistiky $7 D002363
655    _2
$a časopisecké články $7 D016428
700    1_
$a Sanders, Maurits W C B $u Department of Child Neurology, Brain Center University Medical Center Utrecht, the Netherlands. Electronic address: M.W.C.B.Sanders-5@umcutrecht.nl
700    1_
$a Uhrova-Meszarosova, Anna $u Department of Paediatric Neurology, Motol Epilepsy Center, 2nd Faculty of Medicine, Charles University and Motol University Hospital, V Uvalu 84, 15006, Prague, Czech Republic; Neurogenetics Laboratory of the Department of Paediatric Neurology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, V Uvalu 84, Prague, 15006, Czech Republic. Electronic address: anna.meszarosova@lfmotol.cuni.cz
700    1_
$a Belohlavkova, Anezka $u Department of Paediatric Neurology, Motol Epilepsy Center, 2nd Faculty of Medicine, Charles University and Motol University Hospital, V Uvalu 84, 15006, Prague, Czech Republic. Electronic address: anezka.belohlavkova@fnmotol.cz
700    1_
$a Hermanovska, Barbora $u Department of Paediatric Neurology, Motol Epilepsy Center, 2nd Faculty of Medicine, Charles University and Motol University Hospital, V Uvalu 84, 15006, Prague, Czech Republic. Electronic address: barbora.hermanovska@fnmotol.cz
700    1_
$a Novak, Vilem $u Department of Paediatric Neurology, Ostrava Faculty Hospital, 17. Listopadu 1790, 708 00, Ostrava-Poruba, Czech Republic. Electronic address: vilem.novak@fno.cz
700    1_
$a Stanek, David $u Neurogenetics Laboratory of the Department of Paediatric Neurology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, V Uvalu 84, Prague, 15006, Czech Republic. Electronic address: david.stanek@lfmotol.cuni.cz
700    1_
$a Vlckova, Marketa $u Department of Biology and Medical Genetics, 2nd Faculty of Medicine, Charles University and Motol University Hospital, V Uvalu 84, 15006, Prague, Czech Republic. Electronic address: marketa.vlckova@fnmotol.cz
700    1_
$a Zamecnik, Josef $u Department of Pathology and Molecular Medicine, 2nd Faculty of Medicine, Charles University and Motol University Hospital, V Uvalu 84, 15006, Prague, Czech Republic. Electronic address: josef.zamecnik@lfmotol.cuni.cz
700    1_
$a Aronica, Eleonora $u Amsterdam UMC, University of Amsterdam, Department of (Neuro)Pathology, Amsterdam, Meibergdreef 9, 1105, AZ Amsterdam, the Netherlands; Stichting Epilepsie Instellingen Nederland (SEIN), Achterweg 2, 2103, SW, Heemstede, the Netherlands. Electronic address: e.aronica@amsterdamumc.nl
700    1_
$a Braun, Kees P J $u Department of Child Neurology, Brain Center University Medical Center Utrecht, the Netherlands. Electronic address: K.Braun@umcutrecht.nl
700    1_
$a Koeleman, Bobby P C $u Department of Genetics, University Medical Center Utrecht, Utrecht, the Netherlands. Electronic address: B.P.C.Koeleman@umcutrecht.nl
700    1_
$a Jansen, Floor E $u Department of Child Neurology, Brain Center University Medical Center Utrecht, the Netherlands. Electronic address: f.e.jansen@umcutrecht.nl
700    1_
$a Krsek, Pavel $u Department of Paediatric Neurology, Motol Epilepsy Center, 2nd Faculty of Medicine, Charles University and Motol University Hospital, V Uvalu 84, 15006, Prague, Czech Republic. Electronic address: pavel.krsek@fnmotol.cz
773    0_
$w MED00149836 $t European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society $x 1532-2130 $g Roč. 30, č. - (2021), s. 88-96
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33461085 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830101121 $b ABA008
999    __
$a ok $b bmc $g 1690369 $s 1139973
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 30 $c - $d 88-96 $e 20210106 $i 1532-2130 $m European journal of paediatric neurology $n Eur J Paediatr Neurol $x MED00149836
LZP    __
$a Pubmed-20210728

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...